STOCK TITAN

Privia Health Group, Inc. Stock Price, News & Analysis

PRVA Nasdaq

Welcome to our dedicated page for Privia Health Group news (Ticker: PRVA), a resource for investors and traders seeking the latest updates and insights on Privia Health Group stock.

Privia Health Group, Inc. (Nasdaq: PRVA) is a technology-driven physician enablement company that regularly issues detailed updates on its operations, value-based care performance, and network expansion. Its news flow often includes quarterly financial results, guidance updates, and announcements related to Accountable Care Organizations (ACOs) and partnerships with independent physician groups.

Investors following PRVA news can expect recurring earnings releases that highlight metrics such as total revenue, gross profit, operating income, net income, Adjusted EBITDA, Implemented Providers, Value-Based Care Attributed Lives, Practice Collections, Care Margin, and Platform Contribution. The company frequently discusses its performance in the Medicare Shared Savings Program (MSSP) and other value-based arrangements, including aggregate shared savings achieved by its Privia Quality Network ACOs.

Privia Health also uses news releases to announce strategic transactions and geographic expansion. Recent examples include a definitive agreement to acquire an ACO business from Evolent Health, Inc., which serves more than 120,000 attributed lives, and entry into the Arizona market through a partnership with Integrated Medical Services, Inc., a large independent multi-specialty practice. These updates provide insight into how the company is growing its presence across 15 states and the District of Columbia and increasing the number of attributed lives in value-based care arrangements.

In addition, PRVA news may cover governance and board changes, such as the appointment of new directors with technology and cybersecurity expertise. For readers interested in physician enablement, value-based care, and healthcare technology, the Privia Health news feed offers a view into how the company reports its progress, adjusts its full-year guidance, and describes the performance of its physician networks and ACOs over time.

Rhea-AI Summary

Privia Health Group, Inc. (Nasdaq: PRVA) successfully closed its initial public offering (IPO) of 22,425,000 shares at $23.00 each, raising approximately $131.7 million before expenses. The offering consisted of 5,725,000 shares from Privia Health and 16,700,000 shares from a majority stockholder, who will not provide proceeds to Privia. The IPO included the full exercise of the underwriters' option for 2,925,000 additional shares. Trading commenced on April 29, 2021, under the symbol 'PRVA'.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.99%
Tags
-
Rhea-AI Summary

Privia Health Group announced the pricing of its IPO, offering 19.5 million shares at $23.00 each, raising approximately $64.4 million in gross proceeds. The offering includes 2.8 million shares from Privia Health and 16.7 million from its majority stockholder. Shares will begin trading on Nasdaq under the ticker symbol 'PRVA' on April 29, 2021. Proceeds will fund general corporate purposes, including R&D and potential acquisitions, although no agreements are in place for such investments. The offering is set to close on May 3, 2021.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags

FAQ

What is the current stock price of Privia Health Group (PRVA)?

The current stock price of Privia Health Group (PRVA) is $22.37 as of April 10, 2026.

What is the market cap of Privia Health Group (PRVA)?

The market cap of Privia Health Group (PRVA) is approximately 2.9B.